Analysis of retinal sublayer thicknesses and rates of change in ABCA4-associated Stargardt disease

[1]  Kazuhiro Kurokawa,et al.  Cellular Scale Imaging of Transparent Retinal Structures and Processes Using Adaptive Optics Optical Coherence Tomography. , 2020, Annual review of vision science.

[2]  Nathaniel T. Stevens,et al.  Using multiple agreement methods for continuous repeated measures data: a tutorial for practitioners , 2020, BMC Medical Research Methodology.

[3]  J. Sunness,et al.  Abnormal Visual Function Outside the Area of Atrophy Defined by Short-Wavelength Fundus Autofluorescence in Stargardt Disease , 2020, Investigative ophthalmology & visual science.

[4]  M. Michaelides,et al.  Prospective Cohort Study of Childhood-Onset Stargardt Disease: Fundus Autofluorescence Imaging, Progression, Comparison with Adult-Onset Disease, and Disease Symmetry , 2019, American journal of ophthalmology.

[5]  M. Michaelides,et al.  Macular dystrophies: clinical and imaging features, molecular genetics and therapeutic options , 2019, British Journal of Ophthalmology.

[6]  Ian C. Han,et al.  Scleral pits represent degeneration around the posterior ciliary arteries and are signs of disease severity in choroideremia , 2019, Eye.

[7]  M. Vidal-Sanz,et al.  Retinal Ganglion Cell Death as a Late Remodeling Effect of Photoreceptor Degeneration , 2019, International journal of molecular sciences.

[8]  J. Sahel,et al.  Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 12-Month Period: ProgStar Report No. 11. , 2019, JAMA ophthalmology.

[9]  Simon S. Gao,et al.  Correlation of Outer Retinal Degeneration and Choriocapillaris Loss in Stargardt Disease Using En Face Optical Coherence Tomography and Optical Coherence Tomography Angiography. , 2019, American journal of ophthalmology.

[10]  Beatriz Munoz,et al.  Reproducibility of Measurements of Retinal Structural Parameters Using Optical Coherence Tomography in Stargardt Disease , 2019, Translational vision science & technology.

[11]  M. Michaelides,et al.  Cross-Sectional and Longitudinal Assessment of the Ellipsoid Zone in Childhood-Onset Stargardt Disease , 2019, Translational vision science & technology.

[12]  Glenn J. Jaffe,et al.  A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned , 2019, Translational vision science & technology.

[13]  S. Sadda,et al.  Impact of segmentation density on spectral domain optical coherence tomography assessment in Stargardt disease , 2019, Graefe's Archive for Clinical and Experimental Ophthalmology.

[14]  M. Michaelides,et al.  Cross-Sectional and Longitudinal Assessment of Retinal Sensitivity in Patients With Childhood-Onset Stargardt Disease , 2018, Translational vision science & technology.

[15]  J. Sallum,et al.  Relative frequency of inherited retinal dystrophies in Brazil , 2018, Scientific Reports.

[16]  B. Munoz,et al.  Longitudinal Changes of Fixation Location and Stability Within 12 Months in Stargardt Disease: ProgStar Report No. 12. , 2018, American journal of ophthalmology.

[17]  A. Cideciyan,et al.  Visual Acuity Change Over 24 Months and Its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease: ProgStar Study Report No. 10 , 2018, JAMA ophthalmology.

[18]  M. Gillies,et al.  Normative Data for Retinal-Layer Thickness Maps Generated by Spectral-Domain OCT in a White Population. , 2018, Ophthalmology. Retina.

[19]  K. Tsunoda,et al.  Early Patterns of Macular Degeneration in ABCA4-Associated Retinopathy , 2018, Ophthalmology.

[20]  J. García-Feijóo,et al.  Impacts of age and sex on retinal layer thicknesses measured by spectral domain optical coherence tomography with Spectralis , 2018, PloS one.

[21]  Emily J Patterson,et al.  Adaptive optics imaging of inherited retinal diseases , 2017, British Journal of Ophthalmology.

[22]  J. Sahel,et al.  Visual Acuity Change over 12 Months in the Prospective Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: ProgStar Report Number 6. , 2017, Ophthalmology.

[23]  V. Greenstein,et al.  A Comparison of En Face Optical Coherence Tomography and Fundus Autofluorescence in Stargardt Disease , 2017, Investigative ophthalmology & visual science.

[24]  Adam P. DeLuca,et al.  Clinically Focused Molecular Investigation of 1000 Consecutive Families with Inherited Retinal Disease. , 2017, Ophthalmology.

[25]  J. Handa,et al.  Quantifying the Rate of Ellipsoid Zone Loss in Stargardt Disease. , 2017, American journal of ophthalmology.

[26]  V. Greenstein,et al.  Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease , 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.

[27]  B. J. Klevering,et al.  Highly sensitive measurements of disease progression in rare disorders: Developing and validating a multimodal model of retinal degeneration in Stargardt disease , 2017, PloS one.

[28]  R. Adelman,et al.  Novel therapeutics for Stargardt disease , 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.

[29]  M. Yaseri,et al.  STARGARDT DISEASE: Beyond Flecks and Atrophy , 2017, Retina.

[30]  W. MacNee,et al.  Application of Mixed Effects Limits of Agreement in the Presence of Multiple Sources of Variability: Exemplar from the Comparison of Several Devices to Measure Respiratory Rate in COPD Patients , 2016, PLoS ONE.

[31]  David J. Wilson,et al.  Test–Retest Variability of Functional and Structural Parameters in Patients with Stargardt Disease Participating in the SAR422459 Gene Therapy Trial , 2016, Translational vision science & technology.

[32]  Justis P. Ehlers,et al.  ELLIPSOID ZONE MAPPING AND OUTER RETINAL ASSESSMENT IN STARGARDT DISEASE , 2016, Retina.

[33]  J. Sunness,et al.  MAPPING THE DENSE SCOTOMA AND ITS ENLARGEMENT IN STARGARDT DISEASE , 2016, Retina.

[34]  Michel Michaelides,et al.  Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options , 2016, British Journal of Ophthalmology.

[35]  Fang Wang,et al.  Optical Coherence Tomographic Analysis of Retina in Retinitis Pigmentosa Patients , 2016, Ophthalmic Research.

[36]  S. Sadda,et al.  COMPARISON OF MANUAL AND SEMIAUTOMATED FUNDUS AUTOFLUORESCENCE ANALYSIS OF MACULAR ATROPHY IN STARGARDT DISEASE PHENOTYPE , 2016, Retina.

[37]  Donald C Hood,et al.  Near-infrared autofluorescence: its relationship to short-wavelength autofluorescence and optical coherence tomography in recessive stargardt disease. , 2015, Investigative ophthalmology & visual science.

[38]  P. Rosenfeld,et al.  Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies , 2015, The Lancet.

[39]  V. Greenstein,et al.  Correlations among near-infrared and short-wavelength autofluorescence and spectral-domain optical coherence tomography in recessive Stargardt disease. , 2014, Investigative ophthalmology & visual science.

[40]  G. Rebolleda,et al.  Measurement of retinal nerve fiber layer and macular ganglion cell–inner plexiform layer with spectral-domain optical coherence tomography in patients with optic nerve head drusen , 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.

[41]  A. J. Roman,et al.  Inner and outer retinal changes in retinal degenerations associated with ABCA4 mutations. , 2014, Investigative ophthalmology & visual science.

[42]  R. Glynn,et al.  Regression Methods when the Eye is the Unit of Analysis , 2012, Ophthalmic epidemiology.

[43]  R. Molday,et al.  ABCA4 is an N-retinylidene-phosphatidylethanolamine and phosphatidylethanolamine importer , 2012, Nature Communications.

[44]  V. Greenstein,et al.  Transition zones between healthy and diseased retina in choroideremia (CHM) and Stargardt disease (STGD) as compared to retinitis pigmentosa (RP). , 2011, Investigative ophthalmology & visual science.

[45]  G. Fishman,et al.  Spectral-domain OCT peripapillary retinal nerve fibre layer thickness measurements in patients with stargardt disease , 2010, British Journal of Ophthalmology.

[46]  Vikram S Brar,et al.  Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis). , 2009, American journal of ophthalmology.

[47]  Xiaodong Wu,et al.  Automated 3-D Intraretinal Layer Segmentation of Macular Spectral-Domain Optical Coherence Tomography Images , 2009, IEEE Transactions on Medical Imaging.

[48]  A. Bird,et al.  Fundus autofluorescence in Stargardt macular dystrophy-fundus flavimaculatus. , 2004, American journal of ophthalmology.

[49]  Jean Bennett,et al.  Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. , 2004, Human molecular genetics.

[50]  B. Jones,et al.  Neural remodeling in retinal degeneration , 2003, Progress in Retinal and Eye Research.

[51]  B. Lorenz,et al.  Phenotypes of 16 Stargardt macular dystrophy/fundus flavimaculatus patients with known ABCA4 mutations and evaluation of genotype–phenotype correlation , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[52]  D. K. Roberts,et al.  Retrospective, longitudinal, and cross sectional study of visual acuity impairment in choroideraemia , 2002, The British journal of ophthalmology.

[53]  A. Bird,et al.  Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. , 2001, Archives of ophthalmology.

[54]  A. Bird,et al.  Intrafamilial variation of phenotype in Stargardt macular dystrophy-Fundus flavimaculatus. , 1999, Investigative ophthalmology & visual science.

[55]  D. Birch,et al.  Insights into the Function of Rim Protein in Photoreceptors and Etiology of Stargardt's Disease from the Phenotype in abcr Knockout Mice , 1999, Cell.

[56]  J. Lupski,et al.  Corrigendum: A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy , 1997, Nature Genetics.

[57]  J. Lupski,et al.  A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Starqardt macular dystrophy , 1997, Nature Genetics.

[58]  G. Fishman,et al.  Frequency of optic disc or parapapillary nerve fiber layer drusen in retinitis pigmentosa. , 1997, Ophthalmology.

[59]  J. Weiter,et al.  In vivo measurement of lipofuscin in Stargardt's disease--Fundus flavimaculatus. , 1995, Investigative ophthalmology & visual science.

[60]  J. L. Stone,et al.  Morphometric analysis of macular photoreceptors and ganglion cells in retinas with retinitis pigmentosa. , 1992, Archives of ophthalmology.

[61]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[62]  G. Fishman,et al.  Drusen of the optic nerve associated with retinitis pigmentosa. , 1985, Archives of ophthalmology.

[63]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[64]  Angela Jain,et al.  Findings and Lessons Learnt , 2021 .

[65]  A. Cideciyan,et al.  Fixation Location and Stability Using the MP-1 Microperimeter in Stargardt Disease: ProgStar Report No. 3. , 2017, Ophthalmology. Retina.

[66]  M. Sonka,et al.  Retinal Imaging and Image Analysis , 2010, IEEE Reviews in Biomedical Engineering.

[67]  W. Spencer.  Drusen of the optic disk and aberrant axoplasmic transport. The XXXIV Edward Jackson memorial lecture. , 1978, American journal of ophthalmology.